Related Experiment Video
Updated: Sep 26, 2025

Bioinspired Soft Robot with Incorporated Microelectrodes
Published on: February 28, 2020
Multi-labeled neural network model for automatically processing cardiomyocyte mechanical beating signals in drug
Qiangqiang Ouyang1, Wenjian Yang2, Yue Wu2
1Research Center for Intelligent Sensing Systems, Zhejiang Laboratory, Hangzhou, 311100, China; First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, 510006, China.
This study introduces an intelligent platform using artificial neural networks to automatically assess drug-induced cardiotoxicity in preclinical drug development. The system accurately classifies cardiotoxic effects and predicts drug concentrations, enhancing safety screening.
Area of Science:
- Biomedical Engineering
- Pharmacology
- Artificial Intelligence in Drug Discovery
Background:
- High-throughput cardiotoxicity assessment is crucial for preclinical drug development to prevent drug-induced adverse effects.
- Current methods for cardiotoxicity evaluation lack efficiency and intelligence, necessitating advanced platforms.
- Automatic and intelligent drug assessment platforms are in high demand for preclinical cardiotoxicity investigations.
Purpose of the Study:
- To develop an automatic and intelligent strategy for assessing drug-induced cardiotoxicity using cardiomyocytes mechanical beating signals.
- To classify different drugs based on their cardiotoxic effects and predict the severity of cardiotoxicity.
- To improve the efficiency and accuracy of preclinical drug screening for cardiotoxicity.
Main Methods:
- An automatic feature extraction technique was combined with a multi-labeled neural network (MLNN).
- Cardiomyocytes mechanical beating signals were detected using an interdigital electrode biosensor.
- The MLNN processed bio-signal data for classification and prediction of cardiotoxicity.
Main Results:
- The MLNN achieved high accuracy (up to 96%) and AUC (over 98%) in classifying drug-induced cardiotoxicities.
- A high correlation (over 0.90) was observed between MLNN-predicted and actual drug concentrations, indicating accurate severity prediction.
- The intelligent strategy successfully classified cardiotoxic effects and predicted drug concentrations, outperforming conventional methods.
Conclusions:
- The proposed automatic and intelligent strategy demonstrates significant potential for identifying and classifying drug-induced cardiotoxicity.
- This novel bio-signal processing algorithm offers a promising approach for cardiological and pharmaceutical applications in drug safety.
- The system enhances preclinical drug development by providing efficient and accurate cardiotoxicity assessment.
More Related Videos
08:53Human iPSC-Derived Cardiomyocyte Networks on Multiwell Micro-electrode Arrays for Recurrent Action Potential Recordings
Published on: July 15, 2019
11:13Electrophysiological Analysis of human Pluripotent Stem Cell-derived Cardiomyocytes hPSC-CMs Using Multi-electrode Arrays MEAs
Published on: May 12, 2017